Takeda Pharmaceutical Company Limited Operating Income 2011-2026 | TAK

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income Takeda Pharmaceutical Company Limited

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
509 B	100 B	238 B	242 B	156 B	-	-	-	-	-	-

All numbers in JPY currency

Indicator range from annual reports

Maximum	Minimum	Average
509 B	100 B	249 B

Operating Income of other stocks in the Biotechnology industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-508 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	-88.1 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	-8.67 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	-123 M	-	-0.23 %	$ 916 M	USA
Genfit SA GNFT	31.8 M	-	2.54 %	$ 160 B	France
Aileron Therapeutics ALRN	-65.1 M	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	-94.5 M	$ 3.44	2.99 %	$ 303 M	USA
Biophytis SA BPTS	-26.8 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	-452 M	$ 218.06	-1.72 %	$ 5 B	Danmark
Midatech Pharma plc MTP	-7 M	-	-18.52 %	$ 27.3 M	Britain
Amgen AMGN	9.08 B	$ 349.77	0.57 %	$ 188 B	USA
Amphastar Pharmaceuticals AMPH	140 M	$ 19.23	-1.38 %	$ 899 M	USA
Applied Genetic Technologies Corporation AGTC	-17.7 M	-	-	$ 26.5 M	USA
Amarin Corporation plc AMRN	-50.2 M	$ 14.6	0.76 %	$ 6.06 B	Irlanda
AgeX Therapeutics AGE	-9.89 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	-265 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	-16.7 M	-	4.01 %	$ 150 M	Canada
Inventiva S.A. IVA	-52.1 M	$ 6.08	5.19 %	$ 138 M	France
Adverum Biotechnologies ADVM	-139 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-24.6 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-36.3 M	-	-9.65 %	$ 45.9 M	USA
Avenue Therapeutics ATXI	-11.3 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	-241 M	$ 1.4	2.19 %	$ 357 M	Britain
Ayala Pharmaceuticals AYLA	-37.5 M	-	-	$ 7.46 M	Israel
ChemoCentryx CCXI	-130 M	-	-	$ 3.74 B	USA
Aytu BioScience AYTU	-7.83 M	$ 2.63	0.77 %	$ 16.5 M	USA
BioDelivery Sciences International BDSI	37.1 M	-	-4.8 %	$ 255 M	USA
Aeglea BioTherapeutics AGLE	-210 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-412 M	-	-	$ 867 M	Germany
BeiGene, Ltd. BGNE	447 M	-	0.49 %	$ 251 B	Cayman-islands
Bellerophon Therapeutics BLPH	-22.4 M	-	-74.18 %	$ 955 K	USA
Benitec Biopharma BNTC	-9.83 M	$ 11.19	1.91 %	$ 461 M	USA
Akero Therapeutics AKRO	-285 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	-38.2 M	$ 4.42	4.25 %	$ 734 M	Canada
Akouos AKUS	-86.8 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	-11.5 M	-	1.93 %	$ 17.4 M	USA
Allakos ALLK	-196 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	-6.36 M	-	-5.38 %	$ 6.06 M	USA
Allena Pharmaceuticals ALNA	-47.6 M	-	3.16 %	$ 1.9 M	USA
Cabaletta Bio CABA	-172 M	$ 2.82	-4.08 %	$ 3.29 M	USA
Calithera Biosciences CALA	-115 M	-	-10.95 %	$ 876 K	USA
Alpine Immune Sciences ALPN	-58.1 M	-	-	$ 2.17 B	USA
Cara Therapeutics CARA	-121 M	-	-3.03 %	$ 260 M	USA
Ampio Pharmaceuticals AMPE	-33.3 M	-	-11.43 %	$ 502 K	USA
AlloVir ALVR	-46.2 M	-	4.14 %	$ 49.1 M	USA